[Omalizumab in children with uncontrolled asthma: a real-life study carried out in Colombia]

Olga Morales-Múnera1, Ángela Pedraza, Laura Niño-Serna

  • 1Hospital San Vicente Fundación, Departamento de Pediatría, Medellín, Colombia. lavusnino@gmail.com.

Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
|September 4, 2018
PubMed

Insights

Omalizumab significantly improved asthma symptoms in children over 6 years old in real-world use. This add-on therapy reduced controller medication needs and corticosteroid dosages, demonstrating its effectiveness and safety.

Area of Science:

  • Pediatric Pulmonology
  • Allergy and Immunology
  • Pharmacology

Background:

  • Controlled trials confirm omalizumab's efficacy and safety in children over 6 with asthma.
  • Limited real-world studies exist for this demographic.

Purpose of the Study:

  • To evaluate omalizumab's effectiveness as an add-on therapy for moderate to severe persistent asthma in children under real-life conditions.
  • To assess symptom response and changes in medication use.

Main Methods:

  • An observational study with 12-month real-life follow-up.
  • 61 children over 6 years old with moderate to severe persistent asthma were assessed.
  • Asthma control was evaluated before treatment and at 4 and 12 months.

Main Results:

  • Significant symptom improvement observed after 12 months of omalizumab treatment (p = 0.001).
  • Controller drug consumption decreased in 73% of patients; inhaled corticosteroid doses were reduced in 61% and discontinued in 8%.
  • Average inhaled corticosteroid dose significantly decreased (p = 0.02).

Conclusions:

  • Omalizumab is an effective, safe, and well-tolerated add-on therapy for achieving clinical control in moderate to severe allergic asthma.
  • It provides significant benefits for children whose asthma is not adequately managed by standard therapies.
Abstract

Related Concept Videos

Half-life of a Reaction02:42

Half-life of a Reaction

The half-life of a reaction (t1/2) is the time required for one-half of a given amount of reactant to be consumed. In each succeeding half-life, half of the remaining concentration of the reactant is consumed. For example, during the decomposition of hydrogen peroxide, during the first half-life (from 0.00 hours to 6.00 hours), the concentration of H2O2 decreases from 1.000 M to 0.500 M. During the second half-life (from 6.00 hours to 12.00 hours), the concentration decreases from 0.500 M to...
39.1K
Characteristics of Life01:23

Characteristics of Life

Biology is a natural science that studies life and living organisms, including their structure, function, development, interactions, evolution, distribution, and taxonomy. The field's scope is extensive and divided into several specialized disciplines, such as anatomy, physiology, ethology, genetics, and many more. All living things share a few key traits, including cellular organization, heritable genetic material and the ability to adapt/evolve, metabolism to regulate energy needs, the...
261.8K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.5K
The Angiosperm Life Cycle02:39

The Angiosperm Life Cycle

Plants have a life cycle split between two multicellular stages: a haploid stage—with cells containing one set of chromosomes—and a diploid stage—with cells containing two sets of chromosomes. The haploid stage is the gamete-producing gametophyte, and the diploid stage is the spore-producing sporophyte.
72.6K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.4K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K